Joel Greer

21.7k total citations · 1 hit paper
28 papers, 4.6k citations indexed

About

Joel Greer is a scholar working on Nephrology, Hematology and Economics and Econometrics. According to data from OpenAlex, Joel Greer has authored 28 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Hematology and 8 papers in Economics and Econometrics. Recurrent topics in Joel Greer's work include Dialysis and Renal Disease Management (15 papers), Erythropoietin and Anemia Treatment (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Joel Greer is often cited by papers focused on Dialysis and Renal Disease Management (15 papers), Erythropoietin and Anemia Treatment (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Joel Greer collaborates with scholars based in United States and United Kingdom. Joel Greer's co-authors include Erik Thorbecke, James Foster, Robert A. Wolfe, Wendy E. Bloembergen, Raymond M. Hakim, Friedrich K. Port, Caitlin Carroll, John T. Daugirdas, Camille A. Jones and Philip J. Held and has published in prestigious journals such as Econometrica, Kidney International and The American Journal of Medicine.

In The Last Decade

Joel Greer

27 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Class of Decomposable Poverty Measures

1984 3.4k citations James Foster, Joel Greer et al. Econometrica profile →

Peers

Joel Greer

SPS

EE

SR

SS

NEPHR

Sudhir Anand United States

Paul Winters United States

Barbara Sianesi United Kingdom

Douglas Almond United States

David R. Hotchkiss United States

Edwin Leuven Netherlands

Partha Deb United States

David Stifel United States

Jane Falkingham United Kingdom

Joseph V. Terza United States

Sudhir Anand United States

Joel Greer

2.0k ×0.7

SPS

2.0k ×1.5

EE

534 ×0.4

SR

161 ×0.2

SS

143 ×0.2

NEPHR

Citations per year, relative to Joel Greer Joel Greer (= 1×) peers Sudhir Anand

Countries citing papers authored by Joel Greer

Since Specialization

Citations

This map shows the geographic impact of Joel Greer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Greer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Greer more than expected).

Fields of papers citing papers by Joel Greer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Greer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Greer. The network helps show where Joel Greer may publish in the future.

Co-authorship network of co-authors of Joel Greer

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Greer. A scholar is included among the top collaborators of Joel Greer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Greer. Joel Greer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Greer, Joel, et al.. (2025). Fan Perceptions of Dynamic Ticket Pricing in Professional Sports: The Impact of Transparency, Incentives, and Demographics. ScholarWorks@BGSU (Bowling Green State University). 2(1).

2.

Greer, Joel. (2003). End stage renal disease and Medicare.. PubMed Central. 24(4). 1–5. 11 indexed citations

3.

Eggers, Paul W., Diane L. Frankenfield, Joel Greer, et al.. (2002). Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. American Journal of Kidney Diseases. 39(4). 796–804. 9 indexed citations

4.

Hynes, Denise M., Kevin T. Stroupe, Joel Greer, et al.. (2002). Potential cost savings of erythropoietin administration in end-stage renal disease. The American Journal of Medicine. 112(3). 169–175. 40 indexed citations

5.

Rocco, Michael V., et al.. (2001). Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. American Journal of Kidney Diseases. 38(4). 813–823. 15 indexed citations

6.

Thamer, Mae, et al.. (1999). Unequal access to cadaveric kidney transplantation in California based on insurance status.. PubMed. 34(4). 879–900. 28 indexed citations

7.

Port, Friedrich K., Robert A. Wolfe, Caitlin Carroll, et al.. (1996). The dose of hemodialysis and patient mortality. Kidney International. 50(2). 550–556. 433 indexed citations

8.

Thamer, Mae, et al.. (1996). The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states. American Journal of Kidney Diseases. 28(2). 235–249. 9 indexed citations

9.

Bloembergen, Wendy E., Friedrich K. Port, Robert A. Wolfe, et al.. (1996). Relationship of dose of hemodialysis and cause-specific mortality. Kidney International. 50(2). 557–565. 113 indexed citations

10.

Griffiths, Robert I., Neil R. Powe, Joel Greer, et al.. (1994). A review of the first year of Medicare coverage of erythropoietin.. PubMed. 15(3). 83–102. 10 indexed citations

11.

Lissovoy, Gregory de, Neil R. Powe, Robert I. Griffiths, et al.. (1994). The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients. Medical Care. 32(2). 130–140. 17 indexed citations

12.

Eggers, Paul W., Joel Greer, & Stephen F. Jencks. (1994). The Use of Health Care Financing Administration Data for the Development of a Quality Improvement Project on the Treatment of Anemia. American Journal of Kidney Diseases. 24(2). 247–254. 12 indexed citations

13.

Powe, Neil R., Robert I. Griffiths, Joel Greer, et al.. (1993). Early dosing practices and effectiveness of recombinant human erythropoietin. Kidney International. 43(5). 1125–1133. 26 indexed citations

14.

Powe, Neil R., Robert I. Griffiths, Gerard F. Anderson, et al.. (1993). Medicare Payment Policy and Recombinant Erythropoietin Prescribing for Dialysis Patients. American Journal of Kidney Diseases. 22(4). 557–567. 10 indexed citations

15.

Held, Philip J., F K Port, W E Bloembergen, et al.. (1993). Excerpts from the 1993 USRDS Annual Data Report.. PubMed. 22(4 Suppl 2). 1–118. 56 indexed citations

16.

Powe, Neil R., Robert I. Griffiths, G de Lissovoy, et al.. (1992). Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.. PubMed. 268(11). 1434–40. 27 indexed citations

17.

Greer, Joel & Erik Thorbecke. (1986). Food poverty and consumption patterns in Kenya.. 22 indexed citations

18.

Esterik, Penny Van & Joel Greer. (1985). Beer consumption and Third World nutrition. Food Policy. 10(1). 11–13. 5 indexed citations

19.

Foster, James, Joel Greer, & Erik Thorbecke. (1984). A Class of Decomposable Poverty Measures. Econometrica. 52(3). 761–761. 3386 indexed citations breakdown →

20.

Greer, Joel, et al.. (1971). New Orleans asthma. 3. Semiquantitative aerometric pollen sampling, 1967 and 1968.. PubMed. 29(6). 305–17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact